FI894551A - Hybrida monoklonala antikroppar, deras framstaellning och anvaendning. - Google Patents

Hybrida monoklonala antikroppar, deras framstaellning och anvaendning. Download PDF

Info

Publication number
FI894551A
FI894551A FI894551A FI894551A FI894551A FI 894551 A FI894551 A FI 894551A FI 894551 A FI894551 A FI 894551A FI 894551 A FI894551 A FI 894551A FI 894551 A FI894551 A FI 894551A
Authority
FI
Finland
Prior art keywords
deras framstaellning
framstaellning och
hybrid monoclonal
och anvaendning
antikroppar
Prior art date
Application number
FI894551A
Other languages
English (en)
Other versions
FI894551A0 (fi
Inventor
Susumu Iwasa
Tomofumi Kurokawa
Yukio Toyoda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI894551A0 publication Critical patent/FI894551A0/fi
Publication of FI894551A publication Critical patent/FI894551A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6875—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin
    • A61K47/6879—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin the immunoglobulin having two or more different antigen-binding sites, e.g. bispecific or multispecific immunoglobulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI894551A 1988-09-27 1989-09-26 Hybrida monoklonala antikroppar, deras framstaellning och anvaendning. FI894551A (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP24354488 1988-09-27
JP30192588 1988-11-28
JP6294089 1989-03-14
JP16487389 1989-06-27
JP20893689A JP3177776B2 (ja) 1988-09-27 1989-08-11 ハイブリッドモノクローナル抗体，抗体産生ポリドーマおよび抗体含有薬剤

Publications (2)

Publication Number Publication Date
FI894551A0 FI894551A0 (fi) 1989-09-26
FI894551A true FI894551A (fi) 1990-03-28

Family

ID=27523741

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894551A FI894551A (fi) 1988-09-27 1989-09-26 Hybrida monoklonala antikroppar, deras framstaellning och anvaendning.

Country Status (15)

Country Link
US (1) US5506135A (fi)
EP (1) EP0363712B1 (fi)
JP (1) JP3177776B2 (fi)
KR (1) KR900004351A (fi)
CN (1) CN1041783A (fi)
AR (1) AR242832A1 (fi)
AT (1) ATE140930T1 (fi)
AU (1) AU628857B2 (fi)
DE (1) DE68926899T2 (fi)
DK (1) DK474189A (fi)
FI (1) FI894551A (fi)
HU (1) HUT55445A (fi)
IL (1) IL91649A (fi)
NO (1) NO893818L (fi)
PT (1) PT91808B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068322A1 (en) * 1988-04-18 2003-04-10 Immunomedics, Inc. Methods of antibody-directed enzyme-prodrug therapy
TW212184B (fi) * 1990-04-02 1993-09-01 Takeda Pharm Industry Co Ltd
JPH0576385A (ja) * 1990-12-18 1993-03-30 Takeda Chem Ind Ltd キメラ抗体およびその用途
AP257A (en) * 1991-04-26 1993-06-03 Surface Active Ltd A method of releasing an antigen from an antibody and methods for their use in diagnosis and therapy.
JP6473418B2 (ja) * 2013-10-10 2019-02-20 幸成 加藤 抗ポドプラニン抗体
JP7204132B2 (ja) * 2017-05-02 2023-01-16 国立研究開発法人国立がん研究センター プラスミンにより切断可能な抗不溶性フィブリン抗体と薬物とのコンジュゲート

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4714681A (en) * 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
ES8504461A1 (es) * 1982-04-12 1985-04-16 Hybritech Inc Un procedimiento para obtener un polidoma.
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
JP2635343B2 (ja) * 1986-04-14 1997-07-30 ザ・ジェネラル・ホスピタル・コーポレーション ヘテロ二官能性抗体および利用方法

Also Published As

Publication number Publication date
HUT55445A (en) 1991-05-28
AU628857B2 (en) 1992-09-24
EP0363712B1 (en) 1996-07-31
KR900004351A (ko) 1990-04-12
ATE140930T1 (de) 1996-08-15
DE68926899D1 (de) 1996-09-05
EP0363712A3 (en) 1990-08-16
NO893818D0 (no) 1989-09-26
US5506135A (en) 1996-04-09
NO893818L (no) 1990-03-28
EP0363712A2 (en) 1990-04-18
PT91808A (pt) 1990-03-30
JPH03103175A (ja) 1991-04-30
FI894551A0 (fi) 1989-09-26
DK474189D0 (da) 1989-09-26
AU4174789A (en) 1990-04-05
CN1041783A (zh) 1990-05-02
JP3177776B2 (ja) 2001-06-18
AR242832A1 (es) 1993-05-31
IL91649A0 (en) 1990-04-29
DE68926899T2 (de) 1997-01-02
IL91649A (en) 1994-10-21
PT91808B (pt) 1995-05-31
DK474189A (da) 1990-03-28

Similar Documents

Publication Publication Date Title
FI922037A (fi) Uppsvaellbart, brandhaerdigt och elledande bestrykningsmaterial.
FI903845A0 (fi) Renininhibitorer, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI895047A0 (fi) Tienopyridiner, deras framstaellning, mellanprodukter och farmaceutiska sammansaettningar innehaollande dessa foereningar.
FI874772A0 (fi) Fast tvaettmedelreningssammansaettning, omanvaendbar reningsdyna innehaollande densamma och foerfarande foer framstaellning.
FI915404A0 (fi) Endotermiska drivgaser, kompositioner och tillaempningar.
FI914144A0 (fi) Syrabestaendiga betongprodukter, speciellt svavelbetongroer och deras framstaellningfoerfarande.
FI881086A0 (fi) Olja-i-vatten-emulsioner, foerfarande foer deras framstaellning och deras anvaendning.
FI895515A0 (fi) Anslutningsanordning foer handtag, saerskilt i skidstavar, och anvaendarens hand.
FI892874A (fi) Flera laegen intagande, vikbar laenstol med justerbar ryggstoedlutning och sitshoejd.
FI884886A0 (fi) Kaliumkarbonatbaerare, kaliumkatalyter och medelst dessa utfoerda olefindimeriseringsprocesser.
FI882715A (fi) Fenolderivat, deras framstaellning och anvaendning.
FI891061A (fi) Kondenserade kinolinfoereningar, kondenserade akridinfoereningar, foerfarande foer framstaellning daerav och karsinostatiska kompositioner innehaollande desamma.
FI883986A (fi) Tricykliska fusionerade pyrimidinderivat, deras framstaellning och anvaendning.
FI894551A0 (fi) Hybrida monoklonala antikroppar, deras framstaellning och anvaendning.
FI893598A (fi) Sekundaera polyeteraminer, framstaellning av dessa och anvaendning av dessa foer framstaellning av polyuretanderivat.
FI884455A (fi) Renin-haemmande dipeptider, foerfarande foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI895286A0 (fi) Fenyloxipropanolaminer, deras framstaellning och terapeutiska anvaendning.
FI894677A (fi) Basiska 4-aryl-dhp-amider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI903630A0 (fi) Fluoranfoereningar, deras kristallina toluenaddukter, dessa innehaollande upptagningsmaterial och foerfarande foer deras framstaellning.
FI901461A0 (fi) Underrede foer raelsfoerbundna godsvagn, saerskilt foer tankvagnar och kapslade bulkgodsvagnar.
FI891891A (fi) Aminosyraestrar, foerfarande foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI880661A0 (fi) Vatten-i olja-emulsioner, vilka innehaoller amidas och behandlingsfoerfarande foer dylika emulsioner.
FI893498A (fi) Anordning foer pressning, avvattning och filtrering.
FI901958A0 (fi) Reninhaemmande dipeptider, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI904656A0 (fi) Fluoranfoereningar, foerfarande foer deras framstaellning och naemnda foerening innehaollande upptagningsmaterial.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: TAKEDA CHEMICAL INDUSTRIES, LTD.